Diabridge AB is a vehicle to facilitate industry and academia partnerships.
The mission of Diabridge is to support the creation of new improved treatments for diabetes.
Diabridge is a new structure that will bridge the translational gap, and increase the pace of which academic research reach the market/patient.
A team of dedicated project managers with industry experience drives projects from academia, through the sequential phases of drug discovery and development until the research is ready for licensing.
Diabridge AB is founded and owned by scientists within LUDC, Lund University Diabetes Centre, Sweden.